T Danne

Summary

Affiliation: Kinderkrankenhaus auf der Bult
Country: Germany

Publications

  1. ncbi Current practice of insulin pump therapy in children and adolescents - the Hannover recipe
    Thomas Danne
    Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz Korczak Allee, Hannover, Germany
    Pediatr Diabetes 7:25-31. 2006
  2. ncbi Insulin treatment. ISPAD clinical practice consensus guidelines 2006-2007
    Hans-Jacob Bangstad
    Department of Pediatrics, Ulleval University Hospital, Oslo, Norway
    Pediatr Diabetes 8:88-102. 2007
  3. ncbi Current challenges in children with type 1 diabetes
    Thomas Danne
    Pediatr Diabetes 8:3-5. 2007
  4. ncbi New developments in the treatment of type 1 diabetes in children
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Hannover, Germany
    Arch Dis Child 92:1015-9. 2007
  5. ncbi [Type 1 diabetes in children and adolescents--new strategies in management and treatment]
    Olga Kordonouri
    Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz Korczak Allee 1, Hannover
    Med Monatsschr Pharm 31:200-6; quiz 207-8. 2008
  6. ncbi Criteria for Centers of Reference for pediatric diabetes--a European perspective
    Thomas Danne
    Kinder und Jugendlkrankenhaus AUF DER BULT, Janusz Korczak Allee 12, Hannover, Germany
    Pediatr Diabetes 13:62-75. 2012
  7. ncbi Current issues in paediatric diabetology: introduction to Meet-the-Expert sessions
    T Danne
    , Kinderkrankenhaus auf der Bult, Hannover Medical School, Germany
    Horm Res 57:91-2. 2002
  8. ncbi Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Diabetes Zentrum für Kinder und Jugendliche, Janusz Korczak Allee 12, 30173 Hannover, Germany
    Diabetes Care 28:2100-5. 2005
  9. ncbi A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Hannover, Germany
    Pediatr Diabetes 6:193-8. 2005
  10. ncbi Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology
    T Danne
    Kinderkrankenhaus auf der Bult, Janusz Korczak Allee 12, 30173 Hannover, Germany
    Diabetologia 52:1496-503. 2009

Detail Information

Publications46

  1. ncbi Current practice of insulin pump therapy in children and adolescents - the Hannover recipe
    Thomas Danne
    Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz Korczak Allee, Hannover, Germany
    Pediatr Diabetes 7:25-31. 2006
    ..This feature can be helpful, if a trustful relationship between the diabetes team and the family is established...
  2. ncbi Insulin treatment. ISPAD clinical practice consensus guidelines 2006-2007
    Hans-Jacob Bangstad
    Department of Pediatrics, Ulleval University Hospital, Oslo, Norway
    Pediatr Diabetes 8:88-102. 2007
  3. ncbi Current challenges in children with type 1 diabetes
    Thomas Danne
    Pediatr Diabetes 8:3-5. 2007
  4. ncbi New developments in the treatment of type 1 diabetes in children
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Hannover, Germany
    Arch Dis Child 92:1015-9. 2007
  5. ncbi [Type 1 diabetes in children and adolescents--new strategies in management and treatment]
    Olga Kordonouri
    Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Janusz Korczak Allee 1, Hannover
    Med Monatsschr Pharm 31:200-6; quiz 207-8. 2008
    ..Sensor-based insulin treatment is likely to have a significant impact on paediatric diabetes therapy and education in the future...
  6. ncbi Criteria for Centers of Reference for pediatric diabetes--a European perspective
    Thomas Danne
    Kinder und Jugendlkrankenhaus AUF DER BULT, Janusz Korczak Allee 12, Hannover, Germany
    Pediatr Diabetes 13:62-75. 2012
    ..The SWEET project hopes to extend from the initial group of centers within countries, throughout Europe, and beyond with the help of the ISPAD network...
  7. ncbi Current issues in paediatric diabetology: introduction to Meet-the-Expert sessions
    T Danne
    , Kinderkrankenhaus auf der Bult, Hannover Medical School, Germany
    Horm Res 57:91-2. 2002
  8. ncbi Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Diabetes Zentrum für Kinder und Jugendliche, Janusz Korczak Allee 12, 30173 Hannover, Germany
    Diabetes Care 28:2100-5. 2005
    ....
  9. ncbi A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Hannover, Germany
    Pediatr Diabetes 6:193-8. 2005
    ....
  10. ncbi Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology
    T Danne
    Kinderkrankenhaus auf der Bult, Janusz Korczak Allee 12, 30173 Hannover, Germany
    Diabetologia 52:1496-503. 2009
    ..This study was designed to investigate the use and impact of a continuous glucose monitoring system (the FreeStyle Navigator) under home-use conditions in the self-management of type 1 diabetes...
  11. ncbi Real-time glucose sensors in children and adolescents with type-1 diabetes
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Medizinische Hochschule Hannover, Hannover, Germany
    Horm Res 70:193-202. 2008
    ....
  12. ncbi Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial
    Thomas Danne
    Center for Pediatric Endocrinology and Diabetes, Kinderkrankenhaus auf der Bult, Hannover Medical School, Hannover, Germany
    Pediatr Diabetes 9:554-60. 2008
    ..This indicates a less variable absorption with detemir, which is expected to be associated with a more predictable therapeutic effect also in this population...
  13. ncbi Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries
    T Danne
    Kinderkrankenhaus auf der Bult, Hanover, Janusz Korczak Allee 12, 30173 Hanover, Germany
    Diabetologia 51:1594-601. 2008
    ..To assess the use of paediatric continuous subcutaneous infusion (CSII) under real-life conditions by analysing data recorded for up to 90 days and relating them to outcome...
  14. ncbi Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus
    Thomas Danne
    Department of General Pediatrics, Center for Pediatric Endocrinology and Diabetology, Children s Hospital Auf der Bult, Hannover Medical School, Hannover, Germany
    Clin Ther 29:S145-52. 2007
    ..Achieving glycosylated hemoglobin control is a very important aim, but quality-of-life concerns for the child and the family should also have high priority in the management of pediatric DM...
  15. ncbi Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes
    T Danne
    Diabetes Zentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Hannover, Germany
    Acta Paediatr 96:1560-70. 2007
    ....
  16. ncbi Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Hannover, Germany
    Pediatr Diabetes 8:278-85. 2007
    ..regular human insulin (HI) plus NPH] in preschool children with type 1 diabetes...
  17. ncbi Use of technology to potentially preserve C-Peptide in type 1 diabetes mellitus
    Thomas Danne
    The Bult Diabetes Center for Children and Adolescents, Kinderkrankenhaus auf der Bult, Hannover, Germany
    Pediatr Endocrinol Rev 7:396-400. 2010
    ..This may preserve C-peptide and improve outcomes both with and without additional immunomodulatory therapy at the onset of T1DM...
  18. ncbi New insulins and insulin therapy
    T Danne
    Diabetes Zentrum für Kinder and Jugendliche, Kinderkrankenhaus auf der Bult, Hannover, Germany
    Int J Clin Pract 65:26-30. 2011
    ..This has been done by means of PubMed searches as well as a review of abstracts of the recent large international diabetes meetings such as ADA, EASD and ISPAD...
  19. ncbi Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Hannover, Germany
    Diabetes Care 26:3087-92. 2003
    ..Comparisons were also made with NPH insulin to determine any between-treatment difference in the effect of age on pharmacokinetic profile...
  20. ncbi A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes
    Thomas Danne
    Kinderkrankenhaus auf der Bult, Diabetes Zentrum für Kinder und Jugendliche, Hannover, Germany
    Diabetes Care 26:2359-64. 2003
    ..The aim of this study was to compare the glycemic control of preprandial versus postprandial injections of the new rapid-acting insulin analogue aspart in children and adolescents with type 1 diabetes...
  21. ncbi Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group
    T Danne
    Charite Children s Hospital, Humboldt University, Berlin, Germany
    Diabetes Care 24:1342-7. 2001
    ....
  22. ncbi Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy
    Thomas Danne
    Children s Hospital on the Bult, Hannover, Germany
    Diabetes Technol Ther 13:1129-34. 2011
    ..In a prospective study, we investigated the effect of the LGS algorithm on the frequency of hypoglycemia in children and adolescents with type 1 diabetes under real-life conditions...
  23. ncbi Experience with insulin analogues in children
    Thomas Danne
    Diabetes Zentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Hannover, Germany
    Horm Res 57:46-53. 2002
    ....
  24. ncbi Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment
    O Kordonouri
    Bult Diabetes Centre for Children and Adolescents, Kinderkrankenhaus auf der Bult, Janusz Korczak Allee 12, D 30173 Hannover, Germany
    Diabetologia 53:2487-95. 2010
    ....
  25. ncbi [Insulin pump treatment in children and adolescents with type 1 diabetes]
    C Bittner
    Kinderkrankenhaus auf der Bult, , Hannover
    MMW Fortschr Med 146:35-7. 2004
  26. ncbi [Clinical parameters for molecular testing of Maturity Onset Diabetes of the Young (MODY)]
    N Datz
    Diabeteszentrum für Kinder und Jugendliche, Kinderkrankenhaus auf der Bult, Hannover, Deutschland
    Dtsch Med Wochenschr 136:1111-5. 2011
    ..Aim of this study was to evaluate clinical parameters for an efficient screening...
  27. ncbi Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes
    Dorothee Deiss
    Clinic of General Pediatrics, Otto Heubner Centrum, Charite, Campus Virchow Klinikum, Humboldt University, Berlin, Germany
    Pediatr Diabetes 8:157-62. 2007
    ....
  28. ncbi Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus
    O Kordonouri
    Department of Paediatrics, Charite, Humboldt University, Berlin, Germany
    Diabet Med 17:441-4. 2000
    ..To investigate the clinical significance of the determination of IgA antibodies to tissue transglutaminase (tTG) for the detection of silent coeliac disease in patients with Type 1 diabetes mellitus...
  29. ncbi Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany
    O Kordonouri
    Diabetes Centre for Children and Adolescents, Children s Hospital Auf der Bult, Hannover, Germany
    Exp Clin Endocrinol Diabetes 118:245-9. 2010
    ..To determine the prevalence of genetic risk markers of type 1 diabetes (T1D) in children diagnosed at a single centre in Germany and to assess their relation to diabetes-associated autoantibodies...
  30. ncbi Prevalence of latex-specific IgE antibodies in atopic and nonatopic children with type I diabetes
    T Danne
    Children s Hospital, Charite Virchow Clinic, Humboldt University, Berlin, Germany
    Diabetes Care 20:476-8. 1997
    ..The potential induction of allergic sensitization to latex from insulin vial tops stimulated an investigation of the prevalence of specific IgE antibodies to latex in serum and the relationship to atopic disease in children with diabetes...
  31. ncbi Prerequisites for age-appropriate education in type 1 diabetes: a model programme for paediatric diabetes education in Germany
    Karin Lange
    Department of Medical Psychology, Hannover Medical School, Hannover, Germany
    Pediatr Diabetes 8:63-71. 2007
    ..In the context of the Disease-Management-Program for Type 1 Diabetes in Germany these programmes for young people were certified and reimbursed nationwide by health insurances...
  32. ncbi Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes
    O Kordonouri
    Clinics for General Paediatrics and Paediatric Radiology, Otto Heubner Centre, Charite, Campus Virchow Klinikum, Humboldt University, Berlin, Germany
    Diabet Med 19:518-21. 2002
    ..To investigate the prevalence of thyroid autoantibodies and their significance for the development of thyroid disorders in children and adolescents with Type 1 diabetes...
  33. ncbi Age-specific levels of diabetes-related GAD and IA-2 antibodies in healthy children and adults
    Olga Kordonouri
    Children s Hospital, Otto Heubner Centrum, Charite, Humboldt University, Berlin, Germany
    J Pediatr Endocrinol Metab 15:47-52. 2002
    ..027 (at least one antibody elevated). These data emphasize the importance of establishing age-specific reference values for DM-related antibodies in the background population before applying them for screening and intervention studies...
  34. ncbi Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditis
    Olga Kordonouri
    Clinics of General Pediatrics, Otto Heubner Centrum für Kinder und Jugendmedizin Charité, Berlin, Germany
    J Pediatr Endocrinol Metab 17:975-81. 2004
    ..In particular, patients with positive thyroid and anti-nuclear antibodies are at high risk to develop autoimmune thyroiditis during the first 5 years of DM1...
  35. ncbi Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis
    Matthias Meier
    Department of Nephrology, Hannover Medical School, Carl Neuberg Strasse 1, Hannover D 30625, Germany
    J Diabetes Complications 19:223-32. 2005
    ..Future prospective studies with the application of this technique may enable the earlier and more accurate detection of individuals at high risk to develop diabetic nephropathy...
  36. ncbi Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes
    Carine E de Beaufort
    DECCP, Clinique Pédiatrique Centre Hospitalier, Luxembourg
    Diabetes Care 30:2245-50. 2007
    ....
  37. ncbi The global burden of youth diabetes: perspectives and potential
    Henk-Jan Aanstoot
    DIABETER, Centre for Pediatric and Adolescent Diabetes Care and Research, Rotterdam, The Netherlands
    Pediatr Diabetes 8:1-44. 2007
  38. ncbi Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group
    Reinhard W Holl
    University of Ulm, ZIBMT, Albert Einstein Allee 47, 89081 Ulm, Germany
    Eur J Pediatr 162:22-9. 2003
    ..Conclusive evidence, however, should be based on prospectively planned, randomised therapeutic trials in paediatric patients...
  39. ncbi [Type 1 and type 2 diabetes mellitus in Germany. An epidemic in all age groups]
    Thomas Danne
    MMW Fortschr Med 146:27. 2004
  40. ncbi Premixed biphasic insulin analogs - a choice for pediatric patients with type 2 diabetes rather than type 1 diabetes?
    Thomas Danne
    Pediatr Diabetes 7:1-3. 2006
  41. ncbi Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endors
    Moshe Phillip
    Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel
    Diabetes Care 30:1653-62. 2007
  42. ncbi Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study
    Michael Gottschalk
    University of California, San Diego Medical Center, San Diego, CA 92123, USA
    Diabetes Care 30:790-4. 2007
    ..To compare the efficacy and safety of glimepiride versus metformin in pediatric subjects with type 2 diabetes inadequately controlled with diet and exercise alone or oral monotherapy...
  43. ncbi Insulin pumps in pediatrics: we have the technology. We have the evidence. Why are still so few kids using it?
    Thomas Danne
    Pediatr Diabetes 7:2-3. 2006
  44. ncbi Risk of celiac disease in children with type 1 diabetes is modified by positivity for HLA-DQB1*02-DQA1*05 and TNF -308A
    Zdenek Sumnik
    Motol University Hospital, Charles University Prague, V Uvalu 84, CZ 150 06, Prague, The Czech Republic
    Diabetes Care 29:858-63. 2006
    ....
  45. ncbi Parent and health professional perspectives in the management of adolescents with diabetes: development of assessment instruments for international studies
    Hilary Hoey
    Department of Paediatrics, Trinity College, National Children s Hospital, Tallaght, Dublin, 24, Ireland
    Qual Life Res 15:1033-42. 2006
    ..Assessment of quality of life (QOL) in adolescents with diabetes requires patient, parent and health professional input. Psychometrically robust instruments to assess parent and professional perspectives are required...
  46. ncbi Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes
    C Pfleger
    Institute for Clinical Diabetes Research at German Diabetes Centre, Leibniz Institute at Heinrich Heine University Duesseldorf, Auf m Hennekamp 65, 40225 Duesseldorf, Germany
    Clin Immunol 128:57-65. 2008
    ..Blockage of chemokines or antagonism of CCR5 by therapeutic agents such as maraviroc may provide a new therapeutic target to ameliorate disease progression in type 1 diabetes...